Targeted Next-Generation Sequencing Validates the Use of Diagnostic Biopsies as a Suitable Alternative to Resection Material for Mutation Screening in Colorectal Cancer. (2019)
Attributed to:
Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s40291-019-00388-z
PubMed Identifier: 30741375
Publication URI: http://europepmc.org/abstract/MED/30741375
Type: Journal Article/Review
Volume: 23
Parent Publication: Molecular diagnosis & therapy
Issue: 3
ISSN: 1177-1062